Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A clinical trial has confirmed that new HIV treatment Trogarzo suppresses one’s viral load.
According to a systematic review and meta-analysis of dozens of studies, people with HIV have high rates of cardiac dysfunction
A growing global community builds a movement.
In total, about 37 million people are living with HIV, and nearly 53 percent of them are not virally suppressed.
The report notes that governments will “never get to zero on HIV until they reach the trans community.” [VIDEO]
The End AIDS NY 2020 Community Coalition releases a consensus statement on HIV viral load suppression.
The HPTN 052 trial found no transmissions between mixed-HIV-status heterosexual couples when the HIV-positive partner was undetectable.
New findings from the PARTNER trial saw no transmissions within the couples, underlining the power of ARVs to curb the spread of HIV.
The rates of people living with HIV in Ontario, Canada, who are in medical care and who have an undetectable viral load are nearing United Nat...
Those whose CD4 cell levels fail to rise above 200 despite long-term suppression of HIV have a more than doubled risk of death.
There is a vast range in outcomes of success at suppressing HIV with antiretroviral treatment among people taking the drugs in poorer nations.
HIV-positive people with a CD4 count of at least 500 and a fully suppressed viral load as a result of antiretroviral treatment appear to have...
Sustiva (efavirenz) is both safe and no less effective at fighting HIV when the standard dose is reduced by a third.
Disparities in access to care among younger people living with HIV signal a need to better target this group through two strategies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.